All In MedTech

FDA Clearance Tracker · P240006-S014

VARIPULSE™ Platform (VARIPULSE™ Catheter; TRUPULSE™ Generator; Sterile Interface Cable; nGEN™ Pump)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 12, 2026

Approved

Time to decision

86 days

Received Nov 18, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P240006-S014
Device name
VARIPULSE™ Platform (VARIPULSE™ Catheter; TRUPULSE™ Generator; Sterile Interface Cable; nGEN™ Pump)
Applicant location
Irvine, CA
Received
Nov 18, 2025
Decided
Feb 12, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P240006

Device type

Device class
Class III

Every decision under product code QZI

FDA's approval statement

As written in FDA's record.

approval of the protocol updates to align with the PMA approval and to satisfy Central IRB requirements and justify revision of the inclusion criterion

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.